India to South Africa: Liraglutide Export Trade Route

The India to South Africa Liraglutide corridor is one of India's established pharmaceutical export routes, with 3 shipments documented worth a combined $1.4M USD. The route is dominated by ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's liraglutide manufacturing sector.

Across 1 active suppliers, the average shipment value stands at $465.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with liraglutide's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 31.8%, placing it at rank #13 among India's top liraglutide export destinations globally.

On the import side, key buyers of Indian liraglutide in South Africa include M/S MEDPRO PHARMACEUTICA PTY LTD. M/S MEDPRO PHARMACEUTICA PTY LTD is the single largest importer with 3 shipments valued at $1.4M USD.

India's liraglutide exports to South Africa are driven primarily by a handful of large-scale manufacturers. ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMI — together account for 100% of total trade value on this route. The average shipment value of $465.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as giliptra 6mg/ml 3x 3ml prefilled pen (liraglutide injection 18 mg/3 ml (6 mg/ml)(30306 nos) and giliptra 6mg/ml 3x 3ml prefilled pen (liraglutide injection 18 mg/3 ml (6 mg/ml)(7314 nos), suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, M/S MEDPRO PHARMACEUTICA PTY LTD is the largest importer with 3 shipments worth $1.4M USD — representing 100% of all liraglutide imports from India on this route.